References
- Burns R. S., LeWitt P. A., Ebert M. H., Pakkenberg H., Kopin I. J. N Eng J Med 1985; 312: 1418–221
- Miller R. G., Munsat T. L., Swash M., Brooks B. R. For the World Federation of Neurology Committee on Research. Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci 1999; 169: 2–12
- Ricaurte G. A., Deiden L. S., Schuster C. R. Further evidence that amphetamines produce long‐lasting dopamine neurochemical deficits by destroying dopamine nerve fibres. Brain Res 1984; 302: 359–64
- Davidson C., Gow A. J., Lee T. H., Ellinwood E. H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001; 36: 1–22
- Rowland L. P., Shneider N. A. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688–700
- Research Report Series – Methamphetamine Abuse and Addiction, National Institute on Drug Abuse (Accessed March 13, 2006 at http://www.nida.nih.gov/ResearchReports/Methamph/methamph2.html#scope).